Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome

The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects. In particular, the invention relates to methods and compositions selected to monitor cardiorenal syndrome using assays that detect NGAL, preferably tog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: VALKIRS GUNARS, MCPHERSON PAUL H
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator VALKIRS GUNARS
MCPHERSON PAUL H
description The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects. In particular, the invention relates to methods and compositions selected to monitor cardiorenal syndrome using assays that detect NGAL, preferably together with assays that detect natriuretic peptides such as BNP. Such methods and compositions can provide early indications of a deterioration in cardiorenal syndrome status, including prognosis regarding mortality and worsening renal function.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2013122527A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2013122527A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2013122527A13</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEuDqK-w4GzYFLEWYLiUhCjcwnNtR62d-GSxbcXxQdw-of_m1e-wfKQmCFwBCdTkkyFhDP0otAIUxElHr7_SvkJF8VI3ccAMbigkUSRwwj-xVFlwmU168OYcfXrolqfjjd33mCSFnMKHTKW9u7t1tTG2p3dH0z9n3oDL2Y5RA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome</title><source>esp@cenet</source><creator>VALKIRS GUNARS ; MCPHERSON PAUL H</creator><creatorcontrib>VALKIRS GUNARS ; MCPHERSON PAUL H</creatorcontrib><description>The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects. In particular, the invention relates to methods and compositions selected to monitor cardiorenal syndrome using assays that detect NGAL, preferably together with assays that detect natriuretic peptides such as BNP. Such methods and compositions can provide early indications of a deterioration in cardiorenal syndrome status, including prognosis regarding mortality and worsening renal function.</description><language>eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130516&amp;DB=EPODOC&amp;CC=US&amp;NR=2013122527A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20130516&amp;DB=EPODOC&amp;CC=US&amp;NR=2013122527A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VALKIRS GUNARS</creatorcontrib><creatorcontrib>MCPHERSON PAUL H</creatorcontrib><title>Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome</title><description>The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects. In particular, the invention relates to methods and compositions selected to monitor cardiorenal syndrome using assays that detect NGAL, preferably together with assays that detect natriuretic peptides such as BNP. Such methods and compositions can provide early indications of a deterioration in cardiorenal syndrome status, including prognosis regarding mortality and worsening renal function.</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEuDqK-w4GzYFLEWYLiUhCjcwnNtR62d-GSxbcXxQdw-of_m1e-wfKQmCFwBCdTkkyFhDP0otAIUxElHr7_SvkJF8VI3ccAMbigkUSRwwj-xVFlwmU168OYcfXrolqfjjd33mCSFnMKHTKW9u7t1tTG2p3dH0z9n3oDL2Y5RA</recordid><startdate>20130516</startdate><enddate>20130516</enddate><creator>VALKIRS GUNARS</creator><creator>MCPHERSON PAUL H</creator><scope>EVB</scope></search><sort><creationdate>20130516</creationdate><title>Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome</title><author>VALKIRS GUNARS ; MCPHERSON PAUL H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2013122527A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2013</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>VALKIRS GUNARS</creatorcontrib><creatorcontrib>MCPHERSON PAUL H</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VALKIRS GUNARS</au><au>MCPHERSON PAUL H</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome</title><date>2013-05-16</date><risdate>2013</risdate><abstract>The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects. In particular, the invention relates to methods and compositions selected to monitor cardiorenal syndrome using assays that detect NGAL, preferably together with assays that detect natriuretic peptides such as BNP. Such methods and compositions can provide early indications of a deterioration in cardiorenal syndrome status, including prognosis regarding mortality and worsening renal function.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2013122527A1
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T02%3A42%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VALKIRS%20GUNARS&rft.date=2013-05-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2013122527A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true